Bharat biotech company, Biotechnology company

Delhi Chief Minister Arvind Kejriwal on Saturday said that COVID-19 vaccination for the 18-44 age group will be halted from today in the national capital as the vaccine stock for the category has been consumed.Addressing a press conference, he said that Delhi is undergoing a severe vaccine shortage and alleged that the Central government has reduced the vaccine quota of the national capital."Vaccination of the young population is halted from today because the doses that Centre has given us is over so the vaccination centres for young population will be closed. Few doses are remaining which will be sent to some centres, which will be over by today evening. So from tomorrow, all vaccination centres will be closed," he added.Kejriwal informed that he has written a letter to the Central government demanding more vaccines."I have written a letter to the Centre demanding more vaccines and when we will receive vaccines, these centres will resume vaccination drive. Delhi needs 60 lakh doses of vaccine per month, in spite of that, in May, we got 16 lakh doses and, in June, they reduced our quota further, the letter they sent us said that they will only give 8 lakh doses to us in June," he said."To provide vaccines to all adults we need 2.5 crores more doses of vaccines, if we get only 8 lakh doses of vaccines per month, it will take 30 months to complete the vaccination of adults. Then I do not how many more people will die," he added.Citing mass vaccination is only the way to move forward, the Chief Minister said the Central government should ask all interested companies to start manufacturing vaccines as Bharat Biotech company is willing to share their formula with other companies."Right now, the state governments in India are fighting to get vaccines from foreign manufactures. The Government of India should talk to these companies as they will take the Central Government much more seriously," he said."All foreign vaccine manufacturers should be allowed to manufacture vaccines in India," he added.The national capital only recorded 2,200 COVID-19 positive cases in the last 24 hours, the Chief Minister said."Delhi only recorded 2,200 COVID-19 positive cases in the last 24 hours, the positivity rate is only at 3.5 per cent. The danger is not over yet," said Kejriwal.According to Union Health Ministry Delhi has 40,214 active COVID-19 cases. The total number of recoveries has reached 13,47,157 and fatalities have mounted to 22,579.( With inputs from ANI )Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Home

City

Latest News

Cricket

LT Premium

National

International

Maharashtra

Opinions

Chhatrapati Sambhajinagar

Nagpur

Entertainment

Photos

Business

Technology

Sports

Lifestyle

Social Viral

Lokmat Games

Health

Pahalgam Terror Attack

Tahawwur Rana

IPL 2025

CM Devendra Fadnavis

Mumbai Local

Weather Update

Bharat Biotech CompanyFOLLOW

Bharat biotech company, Latest News

National :Chidambaram seeks CAG-driven audit of vaccine production, says mystery of 'missing vaccines' is deepening every day

Congress leader P Chidambaram said on Saturday that the mystery of the "missing vaccines" is deepening every day and a CAG driven full-scope audit of capacity, production, despatch, supply and customers' lists of two domestic manufacturers of COVID- ...

National :Rajasthan govt will appeal to SC to direct Centre to float global tenders for COVID-19 vaccines: Raghu Sharma

Rajasthan Health Minister Dr Raghu Sharma on Thursday said that the state government will appeal to the Supreme Court to direct the Government of India to issue global tenders and procure COVID-19 vaccines. ...

National :Delhi gets its second drive-through vaccination centre at Saket's Select City Walk Mall

A drive-through COVID-19 vaccination centre has been set for all eligible beneficiaries above 18 years of age at Saket's Select City Walk mall in south Delhi. ...

National :Bharat Biotech says EUL for COVAXIN submitted to WHO, approval expected by Jul-Sept 2021

COVID-19 vaccine COVAXIN's manufacturer Bharat Biotech on Tuesday said application for Emergency Use Listing (EUL) of its vaccine has been submitted to World Health Organisation (WHO), Geneva, and regulatory approvals are expected between July and Se ...

National :Paediatric trials of Covaxin may begin in June

Bharat Biotech may begin paediatric trials of its Covid-19 vaccine Covaxin from June, said the company's Business Development and International Advocacy Head Dr Raches Ella on Sunday. ...

National :COVID-19 vaccination for 18-44 age group to be halted in Delhi from today, says CM Kejriwal

Delhi Chief Minister Arvind Kejriwal on Saturday said that COVID-19 vaccination for the 18-44 age group will be halted from today in the national capital as the vaccine stock for the category has been consumed. ...